Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BodyLogicMD vs Hers

BodyLogicMD
Graded #263

Lower grade

vs+0.7999999999999972
Hers
Graded #252

Higher grade

The verdict

Hers takes it — 63.9/100 to 63.1/100, but only just.

Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan. BodyLogicMD is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodyLogicMD +19
73
54
Dose & formulationHers +37
40
77
Clinical oversightBodyLogicMD +5
76
71
Labs & monitoringBodyLogicMD +12
64
52
FulfillmentHers +21
60
81
Contract termsBodyLogicMD +20
61
41
BodyLogicMD · left barHers · right bar

The numbers

MetricBodyLogicMDHers
WeighScore63.1/10063.9/100
GradeCC
Scorecard rank#263#252
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, plus a separate fee, brand-name)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
BodyLogicMD

Graded #263 · C

Strengths

  • Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
  • Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
  • Transparent $79/month membership, no insurance required, cancel anytime

Where it loses points

  • GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
  • Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
  • State availability and dispensing pharmacy are not disclosed on the marketing site
Hers

Graded #252 · C

Strengths

  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard